RRM1 was highly expressed in the papillary (61.9%), tubular (59.6%) and undifferentiated adenocarcinomas (55.4%), but relatively lower in the mucinous (34.4%) and signet ring cell adenocarcinoma subtypes (14.3%). This evidence concerns the gene RRM1 and signet ring cell carcinoma.